J.R. Simplot Company has executed a joint intellectual property licensing agreement with Corteva Agriscience and the Broad Institute of MIT and Harvard for foundational CRISPR-Cas9 and related gene editing tools.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.
